Iron III Hydroxide Polymaltose Complex

Iron (III) Hydroxide Polymaltose Complex (IPC) is a stable, non-ionic iron–carbohydrate complex developed for the treatment and prevention of iron deficiency. Unlike conventional iron salts, iron is present in a polynuclear ferric hydroxide core, stabilized by a polymaltose shell, ensuring controlled iron availability and improved tolerability.

This structure allows iron to be released gradually and in a regulated manner, minimizing free iron exposure and significantly reducing gastrointestinal irritation. Due to its stability, IPC shows a low risk of toxicity and is well tolerated, making it suitable for long-term use.

Key Features:

• Patent held by WBCIL on Iron (III) Hydroxide Polymaltose Complex
• Controlled iron release with reduced GI side effects
• Non-ionic and highly stable iron complex
• Improved patient compliance compared to inorganic iron salts
• Supported by COPP and Written Confirmation (WC)

Applications:

• Iron Deficiency Anemia
• Pediatric and Geriatric Supplementation
• Pregnancy and Lactation
• Long-term Oral Iron Therapy